Found: 206
Select item for more details and to access through your institution.
Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Demonstration of two types of fatigue in subjects with chronic liver disease using factor analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Chronic Hepatitis B Is Associated with Higher Inpatient Resource Utilization and Mortality Versus Chronic Hepatitis C.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Interferon-Free Regimens for Chronic Hepatitis C: Barriers Due to Treatment Candidacy and Insurance Coverage.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Changes in mortality due to Chronic Liver Diseases (CLD) during the COVID-19 pandemic: Data from the United States' National Vital Statistics System.
- Published in:
- PLoS ONE, 2024, v. 19, n. 9, p. 1, doi. 10.1371/journal.pone.0289202
- By:
- Publication type:
- Article
PSYCHOMETRIC PROPERTIES OF THE CHRONIC LIVER DISEASE QUESTIONNAIRE IN PATIENTS WITH CHRONIC LIVER DISEASE.
- Published in:
- Journal of Basic & Clinical Health Sciences, 2023, v. 7, n. 2, p. 671, doi. 10.30621/jbachs.1170430
- By:
- Publication type:
- Article
Modelling the economic and clinical burden of non‐alcoholic steatohepatitis in East Asia: Data from Hong Kong.
- Published in:
- Hepatology Research, 2020, v. 50, n. 9, p. 1024, doi. 10.1111/hepr.13535
- By:
- Publication type:
- Article
Patients With Lean Nonalcoholic Fatty Liver Disease Are Metabolically Abnormal and Have a Higher Risk for Mortality.
- Published in:
- Clinical Diabetes, 2019, v. 37, n. 1, p. 65, doi. 10.2337/cd18-0026
- By:
- Publication type:
- Article
Patients With Diabetes and Chronic Liver Disease Are at Increased Risk for Overall Mortality: A Population Study From the United States.
- Published in:
- Clinical Diabetes, 2017, v. 35, n. 2, p. 79, doi. 10.2337/cd16-0018
- By:
- Publication type:
- Article
Health-related quality of life in patients with autoimmune hepatitis: A questionnaire survey.
- Published in:
- PLoS ONE, 2018, v. 13, n. 10, p. 1, doi. 10.1371/journal.pone.0204772
- By:
- Publication type:
- Article
Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH).
- Published in:
- PLoS ONE, 2018, v. 13, n. 6, p. 1, doi. 10.1371/journal.pone.0199294
- By:
- Publication type:
- Article
Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis.
- Published in:
- Therapeutic Advances in Gastroenterology, 2018, v. 11, p. 1, doi. 10.1177/1756284818811508
- By:
- Publication type:
- Article
The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment.
- Published in:
- Therapeutic Advances in Gastroenterology, 2015, v. 8, n. 5, p. 298, doi. 10.1177/1756283X15587481
- By:
- Publication type:
- Article
Review: Treatment options for nonalcoholic fatty liver disease.
- Published in:
- Therapeutic Advances in Gastroenterology, 2010, v. 3, n. 2, p. 121, doi. 10.1177/1756283X09359964
- By:
- Publication type:
- Article
Reply to Bailly et al.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate Coronavirus Disease 2019 (COVID-19): A Real-World Experience.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 6, p. 1063, doi. 10.1093/cid/ciab579
- By:
- Publication type:
- Article
Not Achieving Sustained Viral Eradication of Hepatitis C Virus After Treatment Leads to Worsening Patient-reported Outcomes.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 4, p. 628, doi. 10.1093/cid/ciz243
- By:
- Publication type:
- Article
Hepatitis C in Patients With Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes.
- Published in:
- Clinical Infectious Diseases, 2018, v. 66, n. 11, p. 1742, doi. 10.1093/cid/cix1106
- By:
- Publication type:
- Article
Evidence for the ectopic synthesis of melanin in human adipose tissue.
- Published in:
- FASEB Journal, 2009, v. 23, n. 3, p. 835, doi. 10.1096/fj.08-116327
- By:
- Publication type:
- Article
Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Hepatic sonic hedgehog protein expression measured by computer assisted morphometry significantly correlates with features of non-alcoholic steatohepatitis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Trends in Liver Transplantation in Hepatitis C Virus-Infected Persons, United States.
- Published in:
- 2016
- By:
- Publication type:
- letter
Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial).
- Published in:
- Patient, 2017, v. 10, n. 5, p. 605, doi. 10.1007/s40271-017-0232-1
- By:
- Publication type:
- Article
Outcomes of hospitalized patients with COVID-19 during the course of the pandemic in a fully integrated health system.
- Published in:
- PLoS ONE, 2022, v. 18, n. 2, p. 1, doi. 10.1371/journal.pone.0263417
- By:
- Publication type:
- Article
Ribavirin-Free RegimenWith Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 8, p. 1042, doi. 10.1093/cid/ciw496
- By:
- Publication type:
- Article
1850-P: High Prevalence of Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis (NASH): The Impact on Patient-Reported Outcomes (PROs).
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1850-P
- By:
- Publication type:
- Article
1449-P: The Enhanced Liver Fibrosis (ELF) Score Predicts Adverse Clinical and Patient-Reported Outcomes in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis (NASH).
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1449-P
- By:
- Publication type:
- Article
1448-P: Enhanced Liver Fibrosis (ELF) Test Can Accurately Predict Advanced Fibrosis in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease (NAFLD).
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1448-P
- By:
- Publication type:
- Article
1529-P: Higher Rates of Disease Progression among Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) Patients with Advanced Fibrosis (AF) and Diabetes Mellitus (DM).
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1529-P
- By:
- Publication type:
- Article
215-LB: Diabetes and Obesity Are the Main Drivers of Increasing Chronic Liver Disease in the United States (U.S.) in the Past Three Decades.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-215-LB
- By:
- Publication type:
- Article
The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH).
- Published in:
- BMC Medical Genetics, 2016, v. 17, p. 1, doi. 10.1186/s12881-016-0324-0
- By:
- Publication type:
- Article
The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19.
- Published in:
- BMC Infectious Diseases, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12879-022-07657-z
- By:
- Publication type:
- Article
Prevalence of metabolic dysfunction‐associated steatotic liver disease in the Middle East and North Africa.
- Published in:
- Liver International, 2024, v. 44, n. 4, p. 1061, doi. 10.1111/liv.15852
- By:
- Publication type:
- Article
The use of current knowledge and non‐invasive testing modalities for predicting at‐risk non‐alcoholic steatohepatitis and assessing fibrosis.
- Published in:
- Liver International, 2023, v. 43, n. 5, p. 964, doi. 10.1111/liv.15555
- By:
- Publication type:
- Article
The impact of fatigue on mortality of patients with non‐alcoholic fatty liver disease: Data from National Health and nutrition examination survey 2005–2010 and 2017–2018.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2646, doi. 10.1111/liv.15437
- By:
- Publication type:
- Article
Increased cancer rates in patients with chronic hepatitis C.
- Published in:
- Liver International, 2020, v. 40, n. 3, p. 685, doi. 10.1111/liv.14305
- By:
- Publication type:
- Article
Hypothetical treatment of patients with non‐alcoholic steatohepatitis: Potential impact on important clinical outcomes.
- Published in:
- Liver International, 2020, v. 40, n. 2, p. 308, doi. 10.1111/liv.14292
- By:
- Publication type:
- Article
Patient‐reported outcomes in patients chronic viral hepatitis without cirrhosis: The impact of hepatitis B and C viral replication.
- Published in:
- Liver International, 2019, v. 39, n. 10, p. 1837, doi. 10.1111/liv.14171
- By:
- Publication type:
- Article
Trends in hospitalizations for chronic liver disease‐related liver failure in the United States, 2005‐2014.
- Published in:
- Liver International, 2019, v. 39, n. 9, p. 1661, doi. 10.1111/liv.14135
- By:
- Publication type:
- Article
Cytokine balance is restored as patient‐reported outcomes improve in patients recovering from chronic hepatitis C.
- Published in:
- Liver International, 2019, v. 39, n. 9, p. 1631, doi. 10.1111/liv.14115
- By:
- Publication type:
- Article
Molecular epidemiology of acute HCV infection in HIV–positive patients from Hong Kong, Taipei, Tokyo.
- Published in:
- Liver International, 2019, v. 39, n. 6, p. 1044, doi. 10.1111/liv.14073
- By:
- Publication type:
- Article
Prevalence and outcomes of non‐alcoholic fatty liver disease (NAFLD) among Asian American adults in the United States.
- Published in:
- Liver International, 2019, v. 39, n. 4, p. 748, doi. 10.1111/liv.14038
- By:
- Publication type:
- Article
Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease.
- Published in:
- Liver International, 2019, v. 39, n. 2, p. 342, doi. 10.1111/liv.13992
- By:
- Publication type:
- Article
Predictors of nonalcoholic steatohepatitis and significant fibrosis in non‐obese nonalcoholic fatty liver disease.
- Published in:
- Liver International, 2019, v. 39, n. 2, p. 332, doi. 10.1111/liv.13983
- By:
- Publication type:
- Article
Viral eradication is required for sustained improvement of patient‐reported outcomes in patients with hepatitis C.
- Published in:
- Liver International, 2019, v. 39, n. 1, p. 54, doi. 10.1111/liv.13900
- By:
- Publication type:
- Article
Improvement of hepatic fibrosis and patient‐reported outcomes in non‐alcoholic steatohepatitis treated with selonsertib.
- Published in:
- Liver International, 2018, v. 38, n. 10, p. 1849, doi. 10.1111/liv.13706
- By:
- Publication type:
- Article
Response to the letter: Hepatitis C screening in opioid epidemics in the United States and societal perspectives.
- Published in:
- Liver International, 2018, v. 38, n. 7, p. 1331, doi. 10.1111/liv.13891
- By:
- Publication type:
- Article
In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered.
- Published in:
- Liver International, 2018, v. 38, n. 2, p. 258, doi. 10.1111/liv.13519
- By:
- Publication type:
- Article
Patient-reported outcomes in patients co-infected with hepatitis C virus and human immunodeficiency virus treated with sofosbuvir and velpatasvir: The ASTRAL-5 study.
- Published in:
- Liver International, 2017, v. 37, n. 12, p. 1796, doi. 10.1111/liv.13462
- By:
- Publication type:
- Article